Moderna đáp trả hàng bằng sáng chế vắc-xin 'vô căn cứ' của đối thủ – Law360 UK

By Jasmin Boyce (May 12, 2023, 6:35 PM EDT) — Drugmaker Moderna has fired back at patent litigation lodged against it by a competitor last year over purportedly poached biotechnology in its coronavirus vaccine known as Spikevax, arguing that the asserted inventions are invalid and the infringement claims can’t hold up in light of safe harbor protections….